Olympic gender confusion: Woman with too much testosterone required to take estrogen to compete while drug that blocks estrogen is banned

Sports Olympic Doping Alan Li JPG
Erik Lief and Chuck Dinersteinย have each weighed in with companion pieces about a highly controversial rule by theย International Association of Athletics Federations (I.A.A.F.), which governs international track and field competition.

[Editorโ€™s note: This is the third in a three-part series on the complicated and fluid issue of gender and sexual identity in elite sports. Read part one and part two.]

South African Caster Semenya, a two-time Olympicย champion in the 800 meters has unusually high levels of testosterone for a woman. While this no doubt plays some part in her successย Semenyaย is not accused of doping; her body just makes more testosterone, whichย I.A.A.F. claims givesย her an unfair advantage. So much so that they have established another classification female athletesย called “differences of sexual development” (DSDs). Theย I.A.A.Fย established a maximum concentration of 5 nanomolesย (a little more than a milligram) per liter (nM/L) of testosterone in blood for women who compete in the 400 m, 800 m, and 1,500 m events. The normal range in women isย 0.12 to 1.79ย nM/L.

At least they’re not beingย tooย unreasonable.

Athletes will not be required to undergo surgery to lower their hormone levels

I.A.A.F.

That leavesย Semenyaย with three choices; not compete, compete against men, or take medication to lower her testosterone levels. It is the last of these that strikes me as rather strange. Should we be forcing athletes to take powerful medications to “correct” whatever advantage they were born with? And if so, there are certainly plenty of genetic advantages that determine size, strength, and endurance. Lung capacity is determined by bothย genetic and environmentalย factors and athletes with greater lung capacity will excel in sports like running and swimming. Michael Phelps has a lung capacity that isย twice that of a normal man. Clearly, this gives him a competitive advantage, but is it unfair? Is the Phelps case all that different from theย Semenya case? Isย Semenyaย being required to take medicine because it is feasible while cutting out one of Phelps’ lungs is not? Where do we draw the line?

The powerful medicine thatย Semenyaย would need to take is hormone replacement therapy (HRT), which is used most commonly by women who are going through menopause and are experiencing unpleasant symptoms, such as hot flashes and also to fight osteoporosis.

There are two types of HRT–estrogen-only and estrogen plus progesterone. Estrogen plus progesterone is used in women who still have a uterusย (have not undergone a hysterectomy) Semenya would be presumably taking estrogens to make herself “more female.”

Will HRT therapy forย some period of time before a competition be harmful? Probably not. Young women withย certain conditionsย are treated with the drugs. But this would be the first time an athlete would be required to take a drug to decrease performance.

And there is a bit of irony here. Cheating is an Olympic sport in the Olympics. This lead the International Olympic Committee to form theย World Anti-Doping Agencyย (WADA) in 1999. WADA’s mission is to ensure that performance-enhancing drugs stay out of sports. The agency is rather strict about what to ban or limit, for example, asthma medications, diuretics, growth hormones, decongestants, and anti-inflammatory steroids (prednisone), to name a few.

Andย Tamoxifen, which blocks the action of estrogen. So, in track and field, a woman with too much testosterone is required to take estrogen to compete while in the Olympics it’s illegal to take another drug that blocks estrogen.

Pretty crazy, no?

Josh Bloom is the Senior Director of Chemical and Pharmaceutical Sciences at the American Council on Science and Health. Follow him on Twitterย @JoshBloomACSH ย 

This article was originally published by the American Council on Science and Health asย Women Athletes & Elevated Testosterone: A Pharmacological View, and has been reproduced here with permission.

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates โ€˜skyrocketingโ€™ as RFK, Jr. and MAHA claims? The evidence says mostly the opposite
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
images
The never-ending GMO debate: Pros and cons
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.